Late August, fall CLO deal pipeline fills; Alcentra NY offers $514.45 million CLO

By Cristal Cody

Tupelo, Miss., Aug. 12 – The CLO pipeline is ramping up with new transactions in the works over late August and fall, including a $514.45 million deal from Alcentra NY LLC, according to market sources on Wednesday.

In other deals on the calendar, Credit Suisse Asset Management, LLC plans to bring the $620 million Madison Park Funding XVIII Ltd./Madison Park Funding XVIII LLC transaction via Morgan Stanley & Co. LLC.

Morgan Stanley also is the placement agent for Anchorage Capital Group, LLC’s $517.5 million Anchorage Capital CLO 7, Ltd./Anchorage Capital CLO 7, LLC deal in the pipeline.

More than $96 billion of CLOs have priced in the U.S. and European primary markets year to date, according to Prospect News data.

Alcentra NY plans to bring a $514.45 million offering of notes due Oct. 20, 2027 in the Shackleton 2015-VIII CLO, Ltd./Shackleton 2015-VIII CLO, LLC transaction, according to a market source.

The deal is expected to include $315.3 million of class A floating-rate notes (AAA); $59.1 million of class B floating-rate notes (AA); $35.6 million of class C deferrable floating-rate notes (A); $25 million of class D deferrable floating-rate notes (BBB); $25 million of class E deferrable floating-rate notes (BB); $10 million of class F deferrable floating-rate notes (B) and $44.45 million of subordinated notes.

J.P. Morgan Securities LLC is the placement agent.

Alcentra will manage the CLO.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.